Omnicell, Inc.
General ticker "OMCL" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $1.7B (TTM average)
Omnicell, Inc. follows the US Stock Market performance with the rate: 48.0%.
Estimated limits based on current volatility of 1.9%: low 45.70$, high 47.48$
Factors to consider:
- Earnings expected soon, date: 2026-07-30 bmo
- Total employees count: 3580 (-2.5%) as of 2025
- US accounted for 91.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Market competition, Technology development, Cybersecurity threats, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [32.05$, 52.29$]
- 2026-12-31 to 2027-12-31 estimated range: [29.33$, 49.12$]
Financial Metrics affecting the OMCL estimates:
- Negative: with PPE of 28.4 at the end of fiscal year the price was high
- Positive: -0.03 < Operating cash flow per share per price, % of 6.02
- Positive: -5.34 < Operating profit margin, % of 0.44
- Positive: 42.57 < Shareholder equity ratio, % of 62.38 <= 64.23
- Positive: -3.72 < Return on assets ratio (scaled to [-100,100]) of 0.10
- Positive: Industry inventory ratio change (median), % of -0.17 <= -0.15
- Negative: negative Industry operating cash flow (median)
Short-term OMCL quotes
Long-term OMCL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,147.11MM | $1,112.24MM | $1,184.85MM |
| Operating Expenses | $1,181.98MM | $1,111.90MM | $1,179.68MM |
| Operating Income | $-34.87MM | $0.34MM | $5.16MM |
| Non-Operating Income | $14.76MM | $25.26MM | $6.17MM |
| R&D Expense | $97.11MM | $90.41MM | $88.67MM |
| Income(Loss) | $-20.11MM | $25.59MM | $11.32MM |
| Taxes | $0.26MM | $13.06MM | $9.27MM |
| Net Income(Loss)* | $-20.37MM | $12.53MM | $2.05MM |
| Stockholders Equity | $1,188.95MM | $1,243.31MM | $1,231.81MM |
| Inventory | $110.10MM | $88.66MM | $100.91MM |
| Assets | $2,226.88MM | $2,120.96MM | $1,974.72MM |
| Operating Cash Flow | $181.09MM | $187.72MM | $127.30MM |
| Capital expenditure | $41.47MM | $36.46MM | $40.41MM |
| Investing Cash Flow | $-55.02MM | $-52.79MM | $-60.36MM |
| Financing Cash Flow | $23.42MM | $-235.58MM | $-218.32MM |
| Earnings Per Share** | $-0.45 | $0.27 | $0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.